Federal scientists must now disclose royalties from government inventions

What it does

This bill requires federal executive branch employees and members of certain science and health advisory committees to disclose royalties they receive from inventions developed during their government work. It mandates that agencies publish these royalty disclosures on their websites, report waivers of conflict-of-interest rules to Congress, and review whether contractors receiving government money have undisclosed royalty conflicts. The bill aims to increase transparency about potential financial conflicts of interest among federal officials and advisors.

Why we flagged it

The bill's core mechanism is mandatory disclosure of royalty income by federal employees and advisory committee members, coupled with congressional notification of ethics waivers and conflict-of-interest reviews for contractors. This is fundamentally an ethics and transparency measure, not a substantive policy change.

What the text implies

• The bill expands the definition of 'covered individuals' to include members of 10+ named advisory committees plus any other advisory committee the GAO determines meets criteria, creating an open-ended class of filers. This could significantly increase the number of people required to disclose royalties.
• Public disclosure of royalty amounts and sources for certain federal employees may create reputational or professional consequences for scientists and researchers, potentially affecting recruitment to government advisory roles.

The full analysis lists 5 implications of this text.

Who it affects

The bill strengthens public accountability by requiring disclosure of financial conflicts of interest among federal employees and advisors who influence public health and science policy. Citizens gain visibility into potential conflicts that could bias government decision-making, and Congress gains tools to oversee ethics compliance.